Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
JPEN. Journal of Parenteral and Enteral Nutrition|October 20, 2007
Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosisJie Cao, Shi-Min Luo, Lijian Liang, et al.
Nutrients|October 27, 2022
Exercise-Induced Muscle Damage and Protein Intake: A Bibliometric and Visual AnalysisFei Xu, Jinshu Zeng, Xuan Liu, et al.
Annals of Hepatology|February 14, 2025
Ethnic differences in metabolic and histologic features among White, Hispanic, Black and Asian patients with metabolic-associated Steatotic liver disease: A network meta-analysisLimin Lin, Jiaming Lai, Ling Luo, et al.
Frontiers of Medicine in China|February 28, 2014
Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosisJie Cao, Shimin Luo, Lijian Liang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 10, 2015
[Experimental study on concentrations and pharmacokinetics of antibiotics in bile and evaluation of their microbicidal potential]Jinglei Zheng, Lijian Liang, Zaiguo Wang, et al.
Biomolecules|September 28, 2023
Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-AnalysisJiaming Lai, Ling Luo, Ting Zhou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 20, 2025
Cytokeratin 18 fragment in liver inflammation and fibrosis: Systematic review and meta-analysisJunzhao Ye, Jiaming Lai, Ling Luo, et al.
BMC Gastroenterology|July 2, 2025
The nomograph predicting the recurrence of Solid Pseudopapillary Neoplasm of the Pancreas: a study of the SEER database and a Chinese cohortQidong Pei, Junzong Chen, Gang Deng, et al.
Apoptosis : an International Journal on Programmed Cell Death|September 26, 2024
Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinomaJiahua Liang, Mingjian Ma, Wei Feng, et al.
Scientific Reports|March 12, 2016
Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical EvidenceWei Chen, Weikai Xiao, Kunsong Zhang, et al.
Pageof 6